Navigation Links
Inovio: DNA delivery technology shows positive human results

Inovio Biomedical’s DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine

Key Milestone for First-in-Man DNA Vaccine Clinical Trial Using Inovio’s Electroporation DNA Delivery Technology


SAN DIEGO, May 22, 2007 -- Inovio Biomedical Corp. (AMEX: INO), focused on the development of DNA-based vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today that interim data from a clinical study of an experimental DNA-based prostate cancer vaccine demonstrated that Inovio’s DNA delivery technology significantly enhanced the potency of the gene-based vaccine.

Dr. Christian H. Ottensmeier, MD, PhD, Cancer Research UK Senior Clinical Research Fellow at the University of Southampton, will present interim data at the 3rd International Conference on DNA Vaccines in Malaga, Spain, from this University of Southampton Phase I/II clinical study of a prostate cancer vaccine, a proprietary product owned by a third party, delivered by Inovio’s electroporation technology. The results demonstrated safety, tolerability and significantly higher antibody responses for patients who received the vaccine with Inovio’s delivery system versus those who were treated without it. Inovio’s electroporation-mediated DNA delivery system is designed to enhance the potency of DNA-based immunotherapies against cancers and infectious diseases.

Inovio Biomedical has been collaborating with Dr. Ottensmeier since 2005 on this University of Southampton clinical study, titled “A Phase I-II Trial of a DNA Vaccine with a PSMA27/pDOM Fusion Gene Given by Intramuscular Injection in HLA2+ Patients with Prostate Carcinomas with or without Electroporation.” This study of patients with recurrent prostate cancer, approved by the United Kingdom Medicines and Healthcare Products Regulatory Agency, is
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
11. Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Inovio DNA delivery technology shows positive human results
(Date:7/30/2015)... , July 30, 2015  Today we bring you a special edition of #MedicareMonday ... remind you about some of our Medicare resources and continue highlighting the success of ... Check out our latest infographics and videos here: ... ... ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)... New York , July 30, 2015 ... of its latest report titled, "Continuous Glucose Monitoring Systems ... 2020". According to the report, the global continuous glucose ... in 2014 and is expected to reach US$ 788.4 ... the forecast period, 2015 to 2020. Global ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... 3 Tapestry,Pharmaceuticals, Inc. (Nasdaq: TPPH ) announced ... multi-center study of TPI 287 in patients with,advanced pancreatic ... the,activity of TPI 287 in various tumor types: the ... hormone refractory prostate cancer. "Currently available taxanes are ...
... Effective for Menopausal ... Women, ... the 2007 Annual Meeting of the North American Menopause Society (NAMS),revealed that ... severe hot flashes associated with,menopause. Additional data presented at the meeting found ...
Cached Medicine Technology:Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes 2
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau ... of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders ... Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New ... It was also the first provider of Exilis non-surgical fat reduction in New ... procedures it has attracted a large International clientele. Many patients travel to New ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The 2nd ... Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight On ... on cancer research between Methodist Healthcare, The West Clinic and The University of Tennessee ...
(Date:7/31/2015)... Jacksonville, FL (PRWEB) , ... July 31, 2015 ... ... has announced an important workshop at its new True North Conference Center. The ... attend so that the Jacksonville community may be more aligned in the effort ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of ... three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology ... from MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... a vascular surgeon at London's Middlesex Hospital, advices passengers, who fly ... death of a woman on board an airliner, while she was ... that long flights can be fatal to many people. ,Dr. ... over reacting.,He says that clot formation can also occur if a ...
... found inside the mouth can lead to oral cancer in ... the patches could become cancerous or not.,Scientists at the University ... leukoplakia, as the patches are known, can be cured and ... in the cells that make up the patches is the ...
... are too small to be picked up by a mammogram, ... candidate for breast cancer. But to offset this problem, scientists ... by Dr. Saraswathi Sukumar, have devised a new method of ... method called ductal lavage. Ductal lavage, involves "washing" breast milk ...
... may opt for mastectomy over breast-conserving lumpectomy if they test ... on Monday. ,About 5% to 10% of all breast ... of these cancers are linked to mutations or alterations in ... carriers have a 55% to 85% risk of breast cancer ...
... tubes in young children who develop fluid in the ears ... new research. ,Currently there are two reasons for ear ... the inner ear cavity of an otherwise healthy child. Doctors ... the second case, children could face long-term developmental impairment. ...
... say that wound healing in depressed people is four times ... find a place in the latest issue of the journal, ... effects on the rate of wound healing, according to the ... affect the immune system, which may keep a wound from ...
Cached Medicine News:Health News:Researchers urge caution in using ear tube surgery 2Health News:Researchers urge caution in using ear tube surgery 3
... state-of-the-art electronic medical record the development of ... a proven, comprehensive electronic medical record designed ... at the point of care and to ... through the Internet. AmkaiCharts chronicles patient history, ...
... Medical Systems Information Technologies ... for yourself how it's ... Office - Practice Management ... can simplify your office ...
... The ReSeeVit 3Z slit lamp is designed ... This video ready slit lamp offers the ... another addition to the ReSeeVit family of ... on the market to capture clear, crisp ...
The AIA-600 II has become the new standard in benchtop immunoassay analyzers....
Medicine Products: